Neurologic and Psychiatric Disorders

Textbook of Clinical Occupational and Environmental Medicine

Volumn , Issue , 2005, Pages 645-694

  Firestone, Jordan A ^a   Longstreth, William T ^b   Pulley, Michael ^c   Berger, Alan R ^c   Fiedler, Nancy ^d   Stein, Lawrence B ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879018593     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-8974-6.50032-4     Document Type: Chapter

References (203)

1. Toxic Substances Control Act (TSCA). Chemical substances inventory - revised inventory synonym and preferred name file 2000, US Government, EPA., Office of Pollution, Prevention, and Toxics, Washington, DC.
2. US Government, EPA. Health Effects Test Guidelines. OPPTS 870 Series. Washington, DC: Office of Prevention, Pesticides, and Toxic Substances (OPPTS); 1998.
3. Neurotoxicity studies. Redbook 2000 - Toxicological Principles for the Safety of Food Ingredients 2000, US Government, FaDA., Center for Food Safety & Applied Nutrition, Office of Premarket Approval, Washington, DC.
4. Claudio L, Kwa WC, Russell AL, Wallinga D Testing methods for developmental neurotoxicity of environmental chemicals. Toxicol Appl Pharmacol 2000, 164:1-14.
5. Feldman RG, Ratner MH The pathogenesis of neurodegenerative disease: neurotoxic mechanisms of action and genetics. Curr Opin Neurol 1999, 12:725-731.
6. Signs and symptoms in neurology 1984, JB Lippincott, Philadelphia, PA. P.D. Swanson (Ed.).
7. Feldman RG Occupational and environmental neurotoxicology 1999, Lippincott-Raven, Philadelphia, PA.
8. Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J Age-specific norms for the Mini-Mental State Exam. Neurology 1988, 38:1565-1568.
9. Mesholam RI, Moberg PJ, Mahr RN, Doty RL Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998, 55:84-90.
10. Wszolek ZK, Markopoulou K Olfactory dysfunction in Parkinson's disease. Clin Neurosci 1998, 5:94-101.
11. Smith DV Assessment of patients with taste and smell disorders. Acta Otolaryngol Suppl 1988, 458:129-133.
12. Kulig BM Comprehensive neurotoxicity assessment. Environ Health Perspect 1996, 104(Suppl 2):317-322.
13. Olanow CW, Arendash GW Metals and free radicals in neurodegeneration. Curr Opin Neurol 1994, 7:548-558.
14. McGuire V, Longstreth WT, Nelson LM, et al. Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol 1997, 145:1076-1088.
15. Woolf AD Ginger Jake and the blues: a tragic song of poisoning. Vet Hum Toxicol 1995, 37:252-254.
16. Glynn P Neuropathy target esterase. Biochem J 1999, 344(Pt 3):625-631.
17. Louis-Ferdinand RT Myelotoxic, neurotoxic and reproductive adverse effects of nitrous oxide. Adverse Drug React Toxicol Rev 1994, 13:193-206.
18. Riess O, Kruger R Parkinson's disease - a multifactorial neurodegenerative disorder. J Neural Transm Suppl 1999, 56:113-125.
19. Cardoso F, Jankovic J Movement disorders. Neurol Clin 1993, 11:625-638.
20. Montastruc JL, Llau ME, Rascol O, Senard JM Drug-induced parkinsonism: a review. Fundam Clin Pharmacol 1994, 8:293-306.
21. Howard JS Cocaine, neuroleptics, and tardive dyskinesia as paleocortical escape. Integr Physiol Behav Sci 1996, 31:306-314.
22. Araki S, Yokoyama K, Murata K Neurophysiological methods in occupational and environmental health: methodology and recent findings. Environ Res 1997, 73(1-2):42-51.
23. Allum JH, Shepard NT An overview of the clinical use of dynamic posturography in differential diagnosis of balance disorders. J Vestib Res 1999, 9:223-252.
24. Forsting M MR imaging of the brain: metabolic and toxic white matter diseases. Eur Radiol 1999, 9:1061-1065.
25. Filley CM Toxic leukoencephalopathy. Clin Neuropharmacol 1999, 22:249-260.
26. Triebig G, Lang C Brain imaging techniques applied to chronically solvent-exposed workers: current results and clinical evaluation. Environ Res 1993, 61:239-250.
27. Lin Z, Chen JD Advances in time-frequency analysis of biochemical signals. Crit Rev Biomed Eng 1996, 24:1-72.
28. Duffy FH, Hughes JR, Miranda F, Bernad P, Cook P Status of quantitative EEG (QEEG) in clinical practice, 1994. Clin Electroencephalogr 1994, 25:VI-XXII.
29. Anger WK, Cassitto MG Individual-administered human behavioral test batteries to identify neurotoxic chemicals. Environ Res 1993, 61:93-106.
30. Anger WK, Otto DA, Letz R Symposium on computerized behavioral testing of humans in neurotoxicology research: overview of the proceedings. Neurotoxicol Teratol 1996, 18:347-350.
31. Bleecker ML, Hansen JA Occupational neurology and clinical neurotoxicology 1994, Williams & Wilkins, Baltimore, MD.
32. Manzo L, Artigas F, Martinez E, et al. Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Hum Exp Toxicol 1996, 15(Suppl 1):S20-S35.
33. Brookes AJ The essence of SNPs. Gene 1999, 234:177-186.
34. Van Zijl PC, Barker PB Magnetic resonance spectroscopy and spectroscopic imaging for the study of brain metabolism. Ann N Y Acad Sci 1997, 820:75-96.
35. Lester DS, Pine DS, Delnomdedieu M, Johannessen JN, Johnson GA Virtual neuropathology: three-dimensional visualization of lesions due to toxic insult. Toxicol Pathol 2000, 28:100-104.
36. Emerging Technologies in the Neurosciences. Proceedings of a conference. Bethesda, MD, March 28-29, 1996. Ann N Y Acad Sci 1997, 820:1-315. Imaging Brain Structure and Function.
37. Philbert MA, Billingsley ML, Reuhl KR Mechanisms of injury in the central nervous system. Toxicol Pathol 2000, 28:43-53.
38. Spencer PS, Schaumburg HH, Ludolph AC Experimental and clinical neurotoxicology 2000, Oxford University Press, New York. 2nd edn.
39. Costa LG The emerging field of ecogenetics. Neurotoxicology 2000, 21:85-89.
40. Cassarino DS, Bennett JP An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Brain Res Rev 1999, 29:1-25.
41. Fleming KC, Adams AC, Petersen RC Dementia: diagnosis and evaluation. Mayo Clin Proc 1995, 70:1093-1107.
42. Porru S, Alessio L The use of chelating agents in occupational lead poisoning. Occup Med (Lond) 1996, 46:41-48.
43. Weiss B, Landrigan PJ The developing brain and the environment: an introduction. Environ Health Perspect 2000, 108(Suppl 3):373-374.
44. Beal MF Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998, 1366:211-223.
45. Langston JW, Ballard P, Tetrud JW, Irwin I Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219:979-980.
46. Kopin IJ Parkinson's disease: past, present, and future. Neuropsychopharmacology 1993, 9:1-12.
47. Degli Esposti M Inhibitors of NADH-ubiquinone reductase: an overview. Biochim Biophys Acta 1998, 1364:222-235.
48. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000, 3:1301-1306.
49. Watters MR Organic neurotoxins in seafoods. Clin Neurol Neurosurg 1995, 97:119-124.
50. Grishin E Polypeptide neurotoxins from spider venoms. Eur J Biochem 1999, 264:276-280.
51. Possani LD, Becerril B, Delepierre M, Tytgat J Scorpion toxins specific for Na+-channels. Eur J Biochem 1999, 264:287-300.
52. Jones RM, Bulaj G Conotoxins - new vistas for peptide therapeutics. Curr Pharm Des 2000, 6:1249-1285.
53. Albin RL Basal ganglia neurotoxins. Neurol Clin 2000, 18:665-680.
54. Ming L Moldy sugarcane poisoning - a case report with a brief review. J Toxicol Clin Toxicol 1995, 33:363-367.
55. Dawson R, Beal MF, Bondy SC, Di Monte DA, Isom GE Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases. Toxicol Appl Pharmacol 1995, 134:1-17.
56. Teitelbaum JS, Zatorre RJ, Carpenter S, et al. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med 1990, 322:1781-1787.
57. Vecsei L, Dibo G, Kiss C Neurotoxins and neurodegenerative disorders. Neurotoxicology 1998, 19:511-514.
58. Spencer PS, Ludolph AC, Kisby GE Are human neurodegenerative disorders linked to environmental chemicals with excitotoxic properties?. Ann N Y Acad Sci 1992, 648:154-160.
59. Snyder SH, Ferris CD Novel neurotransmitters and their neuropsychiatric relevance. Am J Psychiatry 2000, 157:1738-1751.
60. Schaumburg HH, Wisniewski HM, Spencer PS Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exper Neurol 1974, 33:260.
61. Spencer PS, Schaumburg HH Central-peripheral distal axonopathy - the pathogenesis of dying-back polyneuropathies. Progress in neuropathology 1976, 3:253. Grune and Stratton, New York. H. Zimmerman (Ed.).
62. Schaumburg HH, Spencer PS Recognizing neurotoxic disease. Neurology 1987, 37:276.
63. Klassen C Heavy metals and heavy metal antagonists. Goodman and Gilman's the pharmacological basis of therapeutics 1990, 1602. Pergamon Press, Elmsford, New York. Goodman, A. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.).
64. O'Shaughnessy E, Kraft GK Arsenic poisoning: long-term follow-up of a non-fatal case. Arch Phys Med Rehab 1976, 57:403.
65. Windebank AJ, McCall JT, Dyck PJ Metal neuropathy. Peripheral neuropathy 1984, 2133. WB Saunders, Philadelphia. 2nd edn. P.J. Dyck, P.K. Thomas, E.H. Lambert, R.P. Bunge (Eds.).
66. Oh SJ Electrophysiologic profile in arsenic neuropathy. J Neurol Neurosurg Psych 1991, 54:1103.
67. Heyman A, Pfeiffer JB, Taylor HM Peripheral neuropathy caused by arsenical intoxication: a study of 41 cases with observation on the effects of BAL (2,3-dimercapto-propanol). N Engl J Med 1956, 254:401.
68. Feldman RG Occupational and environmental toxicology 1999, 30. Lippincott-Raven Publishers, Philadelphia.
69. Whitfield CL, Ch'ien LT, Whitehead JD Lead encephalopathy in adults. Am J Med 1972, 52:289.
70. Chancellor AM, Slattery JM, Fraser H, Warlow CP Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Disease registry. J Neurol Neurosurg Psych 1993, 56:1200.
71. Seppalainen AM, Hernberg S Sensitive technique for detecting subclinical lead neuropathy. Br J Ind Med 1972, 29:443.
72. Seppalainen AM, Tola S, Hernberg S, Kock B Subclinical neuropathy at 'safe' levels of lead exposure. Arch Environ Health 1975, 30:180.
73. Markowitz ME, Rosen JF Need for the lead mobilization test in children with lead poisoning. J Pediatr 1991, 119:305.
74. Kyrland LT, Faro SN, Siedler H Minamata disease. The outbreak of a neurologic disorder in Minamata, Japan and its relationship to the ingestion of seafood contaminated by mercuric compounds. World Neurol 1967, 1:370.
75. Bakir F, Damluji SF, Amin-Zaki L, et al. Methylmercury poisoning in Iraq. Science 1973, 181:230.
76. Brune D, Evje DM Man's mercury loading from a dental amalgam. Sci Total Environ 1985, 44:51.
77. Takeuchi T Pathology of Minamata disease. Minamata Disease 1968, 141. Study Group of Minamata Disease, Kumamoto University, Japan, Kumamoto. M. Kutsuma (Ed.).
78. Albers JW, Kallenbach LR, Fine LJ, et al. Neurological abnormalities associated with remote occupational elementary mercury exposure. Ann Neurol 1988, 24:651. the Mercury Studies Group.
79. Singer R, Valciukas JA, Rosenman KD Peripheral nerve toxicity in workers exposed to inorganic mercury compounds. Arch Environ Health 1987, 42:181.
80. Campbell D, Gonzales M, Sullivan JB Mercury. Hazardous materials toxicology: clinical principles of environmental health 1992, 824. Williams and Wilkins, Baltimore. J.B. Sullivan, G.R. Kreiger (Eds.).
81. Davis LE, Stadefr JC, Kornfeld M, Abercrombie DM, Butler C Acute thallium poisoning: toxicological and morphological studies of the nervous system. Ann Neurol 1981, 10:38.
82. Douglas KT, Bunni MA, Baindur SR Minireview: thallium in biochemistry. Int J Biochem 1990, 22:429.
83. Nordentoft T, Anderson EB, Morgensen PH Initial sensorimotor and delayed autonomic neuropathy in acute thallium poisoning. Neurotoxicol 1998, 19:421.
84. Dumitru D, Kalantri A Electrophysiologic investigation of thallium poisoning. Muscle Nerve 1990, 13:433.
85. Moore D, House I, Dixon A Thallium poisoning: diagnosis may be elusive but alopecia is the clue. BMJ 1993, 306(6891):1527.
86. Stevens W, van Peteghem C, Heyndricks A, et al. Eleven cases of thallium intoxication treated with Prussian blue. Int J Clin Pharmacol 1974, 10:1.
87. Metcalf DR, Holmes JH EEG, psychological and neurological alterations in humans with organophosphorous exposure. Ann NY Acad Sci 1969, 160:357.
88. Wadia RS, Sadagtopan C, Amin RB, Sardesai HV Neurological manifestations of organophosphorous insecticide poisoning. J Neurol Neurosurg Psych 1974, 37:841.
89. DeBleeker J The intermediate syndrome in organophosphate poisoning: an overview of experimental and clinical observations. Clin Toxicol 1995, 33:683.
90. Wadia RS, Chitra S, Amin RB, Kiwalkar RS, Sardesai HV Electrophysiologic studies in acute organophosphate poisoning. J Neurol Neurosurg Psych 1987, 50:1442.
91. Besser R, Gutman I, Dillmann U, Weilemann LS, Hopf HC End-plate dysfunction in acute organophosphate intoxication. Neurology 1989, 39:561.
92. Misra UK, Nag D, Khan WA, Ray PK A study of nerve conduction velocity, late responses and neuromuscular synapse function in organophosphate workers in India. Arch Toxicol 1988, 61:496.
93. LeWitt P The neurotoxicity of the rat poison vacor. N Engl J Med 1980, 302:73.
94. Watson DF, Griffin JW Vacor neuropathy: ultrastructural and axonal transport studies. J Neuropathol Exp Neurol 1987, 46:96.
95. Gordy ST, Trumper M Carbon disulfide poisoning with a report of six cases. JAMA 1938, 110:1543.
96. Chu C-C, Huang C-C, Chen R-S, Shih T-S Polyneuropathy induced by carbon disulfide in viscose rayon workers. Occup Environ Med 1995, 52:404.
97. Seppalainen AM, Tolonen M Neurotoxicity of long term exposure to carbon disulfide in the viscose rayon industry. A neurophysiologic study. Work Environ Health 1974, 11:145.
98. O'Donoghue JL, Krasavage WJ Hexacarbon neuropathy: a gamma-diketone neuropathy?. J Neuropath Exp Neurol 1979, 38:333. (abst).
99. Mendell JR, Saida K, Ganansia MG, et al. Toxic polyneuropathy produced by methyl n-butyl ketone. Science 1974, 185:787.
100. Schaumburg HH, Spencer PS Environmental hydrocarbons produce degeneration in cat hypothalamus and optic tract. Science 1978, 199:199.
101. Korobkin R, Asbury AK, Sumner AJ, Nielsen SL Glue sniffing neuropathy. Arch Neurol 1975, 32:158.
102. Davenport JG, Farrell DF, Sumi SM 'Giant axonal neuropathy' caused by industrial chemicals: neurofilamentous masses in man. Neurology 1976, 26:919.
103. Asbury AK, Gale MK, Cox SC, Baringer JR, Berg BO Giant axonal neuropathy: a unique case with segmental neurofilamentous masses. Acta Neuropathol 1972, 20:237.
104. He F, Zahng S Effects of allyl chloride on occupationally exposed subjects. Scand J Work Environ Health 1985, 11:43.
105. Gold BG, Griffin JW, Price DL Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration. J Neurosci 1985, 5:1755.
106. Miller MS, Spencer PS Single dose of acrylamide reduce retrograde transport velocity. J Neurochem 1984, 43:1401.
107. Schaumburg HH, Arezzo JC, Spencer PS Delayed onset of axonal neuropathy in primates after prolonged low-level administration of a neurotoxin. Ann Neurol 1989, 26:576.
108. Spencer PS, Schaumburg HH Ultrastructural studies of the dying back process. III. The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol 1977, 36:276.
109. Schaumburg HH, Wisniewski HM, Spencer PS Ultrastructural studies of the dying back process. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol 1974, 33:260.
110. Fullerton PM Electrophysiologic and histologic observations on the peripheral nerves in acrylamide poisoning. J Neurol Neurosurg Psych 1969, 32:186.
111. Pestronk A, Keogh J, Griffin JG Dimethylaminopropionitrile intoxication: a new industrial neuropathy. Neurology 1979, 29:540.
112. Cavalleri F, Galassi G, Ferrari S Methyl bromide induced neuropathy: a clinical, neurophysiological and morphological study. J Neurol Neurosurg Psychiat 1995, 58:383.
113. Gross JA, Haas ML, Swift TR Ethylene oxide neurotoxicity: report of four cases and review of the literature. Neurology 1979, 29:978.
114. Murai Y, Kuroiwa Y Peripheral neuropathy in chlorobiphenyl poisoning. Neurology 1971, 21:1173.
115. Focal peripheral neuropathies 2000, Lippincott, Williams and Wilkins, Philadelphia. J.D. Stewart (Ed.).
116. Mitsunage MM, Nakano K High radial nerve palsy following strenuous muscular activity. Clin Orthop 1988, 234:39.
117. Berger AR, Schaumburg HH Rehabilitation of focal nerve injuries. J Neurol Rehab 1988, 2:65.
118. Entrapment neuropathies 1999, Lippincott, Williams and Wilkins, Philadelphia. D.M. Dawson, M. Hallett, A.J. Wilbourne (Eds.).
119. Berger AR, Herskovitz S Cumulative trauma disorder. Occupational and enviromental neurology 1995, 235. Butterworth-Heinemann, Boston. N.L. Rosenberg (Ed.).
120. Nathan PA, Keniston RC, Myers LD, Meadows KD, Lockwood RS Natural history of median nerve sensory conduction in industry: relationship to symptoms and carpal tunnel syndrome in 558 hands over 11 years. Muscle Nerve 1998, 21:711.
121. Nilsson T, Hagberg M, Berstrom L, Lundstrom R A five-year follow-up of nerve conduction over the carpal tunnel. Stockholm workshop 94. Hand-arm vibration syndrome. Arbete Och Halsa Vetenskaplig skriftserie 1995, 5:117.
122. Campbell CH The effects of snake venoms and their neurotoxins on the nervous system of man and animals. Topics in tropical neurology 1975, 259. FA Davis, Philadelphia. R.W. Hornabrook (Ed.).
123. Gilbert EW, Stewart CM Effective treatment of arachnoidism by calcium salts. Am J Med Sci 1935, 189:532.
124. Cherington M Botulism: ten-year experience. Arch Neurol 1974, 30:432.
125. Warnick JE, Albuquerque EX, Diniz CR Electrophysiologic observations on the action of the purified scorpion venom, Tityustoxin, on nerve and skeletal muscle of the rat. J Pharmacol Exp Ther 1976, 198:155.
126. Evaluation and treatment of myopathies 1995, FA Davis, Philadelphia. R.C. Griggs, J.R. Mendell, R.G. Miller (Eds.).
127. Millar JD Mental health and the workplace: an interchangeable partnership. Am Psychol 1990, 45:1165-1166.
128. Hurley J, Horowitz J Alcohol and health 1990, Sphere Publishing, New York.
129. Harwood JJ, Kristiansen P, Rachal JV Social and economic costs of alcohol abuse and alcoholism. Issue Report No. 2 1985, Research Triangle Institute, Research Triangle Park, NC.
130. Ames GM, Grube JW, Moore RS The relationship of drinking and hangovers to workplace problems: an empirical study. J Stud Alcohol 1997, 58:37-47.
131. Mandell W, Eaton WW, Anthony JC, et al. Alcoholism and occupations: a review and analysis of 104 occupations. Alcohol Clin Exp Res 1992, 16:734-746.
132. Karasek RA Job demands, job decision latitude, and mental strain: implications for job redesign. Adm Sci Q 1979, 24:285-308.
133. Hemmingsson T, Lundberg I Work control, work demands, and work social support in relation to alcoholism among young men. Alcohol Clin Exp Res 1998, 22:921-927.
134. Stansfeld SA, Fuhrer R, Head J, et al. Work and psychiatric disorder in the Whitehall II Study. J Psychosom Res 1997, 43:73-81.
135. Mausner-Dorsch H, Easton WW Psychosocial work environment and depression: epidemiologic assessment of the demand-control model. Am J Public Health 2000, 90:1765-1770.
136. Appelberg K, Romanov K, Heikkila K, et al. Interpersonal conflict as a predictor of work disability: a follow-up study of 15,348 Finnish employees. J Psychosom Res 1996, 40:157-167.
137. Duxbury LE, Higgins CA Gender differences in work-family conflict. J Appl Psychol 1991, 76:60-74.
138. Hochschild A, MacHung A The second shift 1990, Avon Books, New York.
139. Eskanazi B, Maizlish N Effects of occupational exposure to chemicals on neurobehavioural functioning. Medical neuropsychology, the impact of disease on behavior 1988, 223-263. Plenum, New York. R.E. Tarter, D.H. VanThiel, K.L. Edward (Eds.).
140. Schottenfeld RS, Cullen MR Organic affective illness associated with lead intoxication. Am J Psychiatry 1984, 141:1423-1426.
141. Johnson BL, Baker EL, El Batawi M, et al. Prevention of neurotoxic illness in working populations 1987, John Wiley and Sons, New York.
142. Bulletin 48. Organic solvent neurotoxicity 1987, NIOSH., National Institute for Occupational Safety and Health, Washington DC.
143. Chronic effects of organic solvents on the central nervous system and diagnostic criteria 1985, World Health Organization, WHO Regional Office for Europe, Copenhagen.
144. Morrow LA, Ryan CM, Goldstein G, et al. A distinct pattern of personality disturbance following exposure to mixtures of organic solvents. J Occup Med 1989, 31:743-746.
145. Schottenfeld RS, Cullen MR Recognition of occupation-induced post traumatic stress disorders. J Occup Med 1986, 28:365-369.
146. Goldblum D, Chouinard G Schizophrenia psychosis associated with chronic industrial toluene exposure: case report. J Clin Psychiatry 1985, 46:350-351.
147. Dager SR, Holland JP, Cowley DS, et al. Panic disorder precipitated by exposure to organic solvents in the work place. Am J Psychiatry 1987, 144:1056-1058.
148. Ely EW, Moorehead B, Haponik EF Warehouse workers' headache: emergency evaluation and management of 30 patients with carbon monoxide poisoning. Am J Med 1995, 98:145-155.
149. Lezak MD Neuropsychological assessment 1995, Oxford University Press, New York.
150. Meredith T, Vale A Carbon monoxide poisoning. Br Med J 1988, 296:77-79.
151. Min SK A brain syndrome associated with delayed neuropsychiatric sequelae following acute carbon monoxide intoxication. Acta Psychiatr Scand 1986, 73:80-86.
152. Ernst A, Zibrak JD Carbon monoxide poisoning. N Engl J Med 1998, 339:1603-1608.
153. Choi IS Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 1983, 40:433-435.
154. Maghazaji HI Psychiatric aspects of methylmercury poisoning. J Neurol Neurosurg Psychiatry 1974, 37:954-958.
155. Gross LS, Nagy RM Neuropsychiatric aspects of poisonous and toxic disorders. American Psychiatric Press textbook of psychiatry 1992, American Psychiatric Press, Washington DC. 2nd edn. S.C. Yudofsky, R.E. Hales (Eds.).
156. Menzies D, Bourbeau J Building-related illnesses. N Engl J Med 1997, 337:1524-1531.
157. Redlich CA, Sparer J, Cullen MR Sick-building syndrome. Lancet 1997, 349:1013-1016.
158. Bauer RM, Greve KW, Besch EL, et al. The role of psychological factors in the report of building-related symptoms in sick building syndrome. J Consult Clin Psychol 1992, 60:213-219.
159. Loewen L, Suedfeld P Cognitive and arousal effects of masking office noise. Environ Behav 1992, 24:381-395.
160. Bing-shuang H, Yue-lin Y, Ren-yi W, et al. Evaluation of depressive symptoms in workers exposed to industrial noise. Homeostasis Health Dis 1997, 38:123-125.
161. Dejoy DM Information input rate, control over task pacing, and performance during and after noise exposure. J Gen Psychol 1985, 11:229-242.
162. Akerstedt T Psychological and psychophysiologic effects of shift work. Scand J Work Environ Health 1990, 16:67-73.
163. Frese M, Semmer N Shiftwork, stress, and psychosomatic complaints: a comparison between workers in different shiftwork schedules, non-shiftworkers, and former shiftworkers. Ergonomics 1986, 29:99-114.
164. Verhaegen P, Dirkx J, Maasen A, et al. Subjective health after twelve years of shift work. Night and shiftwork: longterm effects and their prevention 1986, 67-74. Verlag Peter Lang, Frankfurt Am Main. M. Haider (Ed.).
165. Costa G, Apostali P, D'Andrea F, et al. Gastrointestinal and neurotic disorders in textile shift workers. Night and shift work: biologic and social aspects 1981, 187-196. Pergamon Press, Oxford. A. Reinberg, N. Vieux, P. Andlauer (Eds.).
166. Harma M, Illmarinen J, Knauth P Physical fitness and other individual factors relating to the shiftwork tolerance of women. Chronobiol Int 1988, 5:417-424.
167. Tasto DL, Colligan MJ, Skjel EW, et al. Health consequences of shift work (SRI Project URU-4426) 1978, US Department of Health, Education and Welfare, NIOSH, Washington DC.
168. Cole R, Loving R, Kripke D Psychiatric aspects of shiftwork. Occupational medicine: state of the art reviews 1990, Hanley & Belfus, Philadelphia. A. Scott (Ed.).
169. Keyserling WM Occupational safety preventing accidents and overt trauma. Occupational health: recognizing and preventing work-related disease and injury 2000, 181-194. Lippincott Williams & Wilkins, Philadelphia. 4th edn. B.S. Levy, D.H. Wegman (Eds.).
170. Regehr C, Hill J, Glancy G Individual predictors of traumatic reactions in firefighters. J Nerv Ment Dis 2000, 188:333-339.
171. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, APA, Washington DC. 4th edn.
172. Kawamoto T, Koga M, Murata K, et al. Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans. Toxicol Appl Pharmacol 1995, 133:295-304.
173. Soderkvist P, Ahmadi A, Akerback A, et al. Glutathione S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy. Scand J Work Environ Health 1996, 22:360-363.
174. Maslach C, Jackson SE, Lieter MP Maslach burnout inventory manual 1996, Consulting Psychologists Press, Palo Alto.
175. Bulletin 57. Violence in the workplace: risk factors and prevention strategies 1996, NIOSH., National Institute of Occupational Safety and Health, Washington DC.
176. Tucker P, Trautman R Understanding and treating PTSD: past, present, and future. Bull Menninger Clin 2000, 64:37-51.
177. Porras JL, Silvers RC Organizational development and transformation. Ann Rev Psychol 1991, 42:51-78.
178. Cordery KL, Mueller WS, Smith LM Attitudinal and behavioral effects of autonomous group work: a longitudinal field study. Acad Manage J 1991, 34:464-476.
179. Warren J, Johnson P The impact of workplace support on work-family role strain in family relations. J Appl Fam Child Stud 1995, 44:163-169.
180. Barling J, Barenbug A Some personal consequences of 'flextime' work schedules. J Soc Psychol 1984, 123:137-138.
181. McGovern P, Dowd B, Gherdingen D, et al. Time off work and the postpartum health of employed women. Med Care 1997, 35:507-521.
182. Caudron S The wellness payoff. Pers J 1990, 69:54-60.
183. Adamson DW, Gardner MD Employee assistance programs and managed care: merge and converge. Managed mental healthcare: major diagnostic and treatment approaches 1997, 67-82. Brunner/Mazel, Inc., Bristol. S.R. Sauber (Ed.).
184. Cooper CL, Sadri G The impact of stress counselling at work. J Soc Behav Pers 1991, 6:411-423.
185. Guppy A, Marsden J Assisting employees with drinking problems: changes in mental health, job perceptions and work performance. Work Stress 1997, 11:341-350.
186. Mitchie S Reducing absenteeism by stress management: valuation of a stress counselling service. Work Stress 1996, 10:367-372.
187. Ramanathan CS EAP's response to personal stress and productivity: implications for occupational social work. Soc Work 1992, 37:234-239.
188. Walsh DC, Hingson RW, Merrigan DM, et al. A randomized trial of treatment options for alcohol-abusing workers. N Engl J Med 1991, 325:775-782.
189. Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992, 49:761-768.
190. Hogarty GE, McEvoy JP, Munetz M, et al. Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia: results of a two-year controlled study. Arch Gen Psychiatry 1988, 45:797-805.
191. Sperry L Psychiatric consultations in the workplace 1993, American Psychiatric Press, Washington DC.
192. The Americans with Disabilities Act: Questions and Answers 1991, United States Department of Justice, Civil Rights Division, US Department of Justice, Washington DC.
193. Carling PJ Reasonable accommodations in the workplace for individuals with psychiatric disabilities. Consult Psychol J 1993, 46-62.
194. Anthony WA, Jansen MA Predicting the vocational capacity of the chronically mentally ill. Am Psychol 1984, 39:537-544.
195. Massel HK, Liberman RP, Mintz J, et al. Evaluating the capacity to work of the mentally ill. Psychiatry 1990, 53:31-43.
196. Mental health consumers in the work place: how the Americans with Disabilities Act protects you against employment discrimination 1992, Mental Health Law Project, Mental Health Law Project, Washington DC.
197. Beck AT Beck anxiety inventory 1993, The Psychological Corporation, San Antonio.
198. Beck AT Beck depression inventory 1978, The Psychological Corporation, San Antonio.
199. Derogatis LR. SCL-90-R administration, scoring and procedures manual-III. Towson: Clinical Psychometric Research, 1983.
200. Dohrenwend BS, Krasnoff L, Askenasy AR, et al. Exemplification of a method for scaling life events: the peri life events scale. J Health Soc Behav 1978, 19:205-229.
201. Horowitz M, Wilner N, Alvarez W Impact of event scale: a measure of subjective stress. Psychosom Med 1979, 41:209-218.
202. Karasek R, Theorell T Healthy work 1990, Basic Books, New York.
203. Selzer ML, Vinokur A, Van Rooijen L A self-administered short Michigan screening test. J Stud Alcohol 1975, 36:117-126.